South Africa Interventional Cardiology Devices Market Size & Outlook, 2025-2033
South Africa Interventional Cardiology Devices Market Insights
- According to Reed Intelligence analysis, the South Africa Interventional Cardiology Devices Market size was USD 159.6 Million in 2024 and is projected to reach USD 291.15 Million by 2033.
- The South Africa market is projected to grow at a CAGR of 6.88% between 2025 and 2033.
- By segment, Coronary Stents emerged as the largest By Product Type in terms of market size in 2024.
- Other Product Types is anticipated to remain the most attractive By Product Type segment, recording the fastest growth during the forecast period.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- South Africa accounted for 1.12% of the global Interventional Cardiology Devices Market size in 2024.
- By 2033, United States is expected to remain the top global market in terms of size.
- Within Middle East and Africa, United Arab Emirates is forecasted to dominate the regional Interventional Cardiology Devices Market size by 2033.
- Turkey will be the fastest-growing market in Middle East and Africa, projected to achieve USD 160.87 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 159.6 Million |
| Market Size In 2033 | USD 291.15 Million |
| Largest segment | Coronary Stents |
| Units | Revenue in USD Million |
| CAGR | 6.88% (2025-2033) |
| Segmnetation Covered | |
| By Product Type |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
South Africa Interventional Cardiology Devices Market By Product Type 2025-2033 (USD Million)
| By Product Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coronary Stents | XX.x | XX.x | XX.x | 56.27 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Catheters | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Other Product Types | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
